All articles tagged with #ozempic
Health experts warn that GLP-1 weight-loss drugs like Ozempic can cause substantial lean-mass loss in a sizable portion of users, potentially accelerating sarcopenia and increasing fall risk, especially among older adults; however, doctors advise mitigating strategies such as high-protein diets, regular strength training, and close medical follow-up to preserve muscle while maintaining weight-loss benefits.
The Independent explains that popular weight‑loss injections can have unwanted side effects and provides practical steps to manage them, including discussing dosing with a clinician, monitoring symptoms, and maintaining adequate nutrition to meet vitamin and mineral needs.
A study shows that individuals who stop using GLP-1 drugs like Ozempic and Wegovy tend to regain their lost weight within about 18 months, and those who used these drugs regain weight four times faster than those relying solely on diet and exercise. For long-term health benefits, lasting lifestyle changes are essential.
A review of research indicates that individuals who stop using GLP-1 drugs like Ozempic and Wegovy for weight loss tend to regain their lost weight within approximately 18 months, and this regain occurs faster than with behavioral methods like dieting or exercise. To maintain health benefits after discontinuing these medications, lasting lifestyle changes are essential.
Doctors warn that weight-loss drugs like Ozempic and Wegovy, originally for diabetes, carry risks such as side effects and potential weight regain after stopping, emphasizing the importance of lifestyle changes and caution against viewing these medications as quick fixes.
Oatzempic, a fad involving oats blended into a drink, is not supported by scientific evidence as a weight-loss alternative like Ozempic. While oats can promote fullness due to their fiber content, they do not have the powerful hormonal effects of medication and should be part of a balanced diet rather than a standalone solution. Long-term weight management requires comprehensive lifestyle changes, not reliance on fad drinks.
Oatzempic is a social media trend involving oats blended with water or juice, claimed to promote weight loss by increasing fullness, but it lacks scientific evidence and does not work like the prescription drug Ozempic. While oats and other high-fiber foods can modestly improve appetite control and health, they are not a magic solution for weight loss. Sustainable weight management requires a balanced diet, physical activity, and lifestyle changes, not relying solely on fiber-rich drinks.
Berberine, often called 'nature's Ozempic,' is a natural supplement that shows promise for weight loss and managing blood sugar, but it is not a miracle cure and should be used cautiously under medical advice. It may help with cholesterol, diabetes, and insulin resistance, and could support weight loss when combined with lifestyle changes, though it is not a direct substitute for prescription medications like Ozempic.
A recent study shows that bariatric surgery results in about five times more weight loss over two years compared to GLP-1 medications like Ozempic, highlighting surgery's superior long-term effectiveness for obesity treatment.
The article explores the impact of Ozempic, a medication for diabetes and weight management, on the workplace, suggesting it may influence employee health and productivity. However, access to the full content requires a subscription.
Novo Nordisk's stock, after a significant decline in 2025 due to competition and market pressures, could rebound strongly in 2026 with the FDA approval of its oral Wegovy pill, a major development in obesity treatment. The new pill is expected to boost the company's growth prospects, potentially leading to a substantial stock price increase and making it an attractive investment opportunity, especially if the company maintains or exceeds its current growth rate.
The article discusses the potential of Ozempic (semaglutide), a drug primarily used for diabetes and obesity, to treat early-stage Alzheimer's disease, highlighting upcoming clinical trial results that could signal a breakthrough in Alzheimer's treatment.
Women using Ozempic for weight loss are experiencing side effects like sagging and changes in their genital area, leading some to seek cosmetic procedures such as labia puffing with fillers to restore appearance, despite potential risks. The phenomenon, dubbed 'Ozempic vagina,' highlights unintended aesthetic and health consequences of rapid weight loss from GLP-1 medications.
Women taking Ozempic report experiencing 'Ozempic vulva,' a side effect causing changes in vaginal appearance, leading some to spend up to £2,000 on corrective procedures like labia puffing with fillers. Experts warn about potential risks and emphasize the importance of consulting qualified healthcare providers, while the manufacturer advises using the medication only for approved indications and reporting side effects.
A study shows that bariatric surgery results in significantly greater and more durable weight loss compared to GLP-1 medications like Ozempic, with surgery patients losing an average of 25.7% of their body weight over two years versus 5.3% for medication users, highlighting the superior effectiveness of surgery despite its invasiveness.